Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM m...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2024-03-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304223003252 |
_version_ | 1797731023006466048 |
---|---|
author | Yancheng Lai Xiaole Lu Yankai Liao Pei Ouyang Hai Wang Xian Zhang Guanglong Huang Songtao Qi Yaomin Li |
author_facet | Yancheng Lai Xiaole Lu Yankai Liao Pei Ouyang Hai Wang Xian Zhang Guanglong Huang Songtao Qi Yaomin Li |
author_sort | Yancheng Lai |
collection | DOAJ |
description | Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM malignant progression and recurrence, which might be a breakthrough to understand GBM heterogeneity and overcome treatment resistance. PMT is a complicated process influenced by crosstalk between GBM and tumor microenvironment, depending on intricate ligand-receptor interactions. In this review, we summarize the autocrine and paracrine pathways in the GBM microenvironment and related ligand-receptor interactions inducing PMT. We also discuss the current therapies targeting the PMT-related autocrine and paracrine pathways. Together, this review offers a comprehensive understanding of the failure of GBM-targeted therapy and ideas for future tendencies of GBM treatment. |
first_indexed | 2024-03-12T11:52:57Z |
format | Article |
id | doaj.art-6c4a8cd8dd684b6c96fc58b3b5060b77 |
institution | Directory Open Access Journal |
issn | 2352-3042 |
language | English |
last_indexed | 2024-03-12T11:52:57Z |
publishDate | 2024-03-01 |
publisher | KeAi Communications Co., Ltd. |
record_format | Article |
series | Genes and Diseases |
spelling | doaj.art-6c4a8cd8dd684b6c96fc58b3b5060b772023-08-31T05:03:11ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422024-03-01112874889Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactionsYancheng Lai0Xiaole Lu1Yankai Liao2Pei Ouyang3Hai Wang4Xian Zhang5Guanglong Huang6Songtao Qi7Yaomin Li8Department of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Corresponding authors. Guangzhou Dadao Bei Street 1838#, Guangzhou, Guangdong 510515, China. Fax: +86 20 61641806.Department of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Corresponding authors. Guangzhou Dadao Bei Street 1838#, Guangzhou, Guangdong 510515, China. Fax: +86 20 61641806.Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM malignant progression and recurrence, which might be a breakthrough to understand GBM heterogeneity and overcome treatment resistance. PMT is a complicated process influenced by crosstalk between GBM and tumor microenvironment, depending on intricate ligand-receptor interactions. In this review, we summarize the autocrine and paracrine pathways in the GBM microenvironment and related ligand-receptor interactions inducing PMT. We also discuss the current therapies targeting the PMT-related autocrine and paracrine pathways. Together, this review offers a comprehensive understanding of the failure of GBM-targeted therapy and ideas for future tendencies of GBM treatment.http://www.sciencedirect.com/science/article/pii/S2352304223003252AutocrineGlioblastomaLigand-receptor interactionMicroenvironmentParacrineProneural-mesenchymal transition |
spellingShingle | Yancheng Lai Xiaole Lu Yankai Liao Pei Ouyang Hai Wang Xian Zhang Guanglong Huang Songtao Qi Yaomin Li Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions Genes and Diseases Autocrine Glioblastoma Ligand-receptor interaction Microenvironment Paracrine Proneural-mesenchymal transition |
title | Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions |
title_full | Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions |
title_fullStr | Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions |
title_full_unstemmed | Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions |
title_short | Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions |
title_sort | crosstalk between glioblastoma and tumor microenvironment drives proneural mesenchymal transition through ligand receptor interactions |
topic | Autocrine Glioblastoma Ligand-receptor interaction Microenvironment Paracrine Proneural-mesenchymal transition |
url | http://www.sciencedirect.com/science/article/pii/S2352304223003252 |
work_keys_str_mv | AT yanchenglai crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT xiaolelu crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT yankailiao crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT peiouyang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT haiwang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT xianzhang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT guanglonghuang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT songtaoqi crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions AT yaominli crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions |